These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The effect of a carbonic anhydrase inhibitor, diamox, on human pancreatic secretion. DREILING DA, JANOWITZ HD, HALPERN M. Gastroenterology; 1955 Aug; 29(2):262-79. PubMed ID: 13251415 [No Abstract] [Full Text] [Related]
11. Inhibition of bovine carbonic anhydrase by new sulfonamide compounds. Arslan O. Biochemistry (Mosc); 2001 Sep; 66(9):982-3. PubMed ID: 11703179 [Abstract] [Full Text] [Related]
12. [Clearance tests of kidney function in patients treated with 2-acetylamino-1,3,4-thiadiazole-5-sulfonamide (diamox)]. REITANO U, BONANNO S. Riforma Med; 1955 Oct 01; 69(40):1097-105. PubMed ID: 13267313 [No Abstract] [Full Text] [Related]
13. Inhibition of human pancreatic secretion by diamox (carbonic anhydrase inhibitor; therapeutic implications in pancreatitis. DREILING DA, JANOWITZ HD. Surg Forum; 1955 Oct 01; 5():414-20. PubMed ID: 13247063 [No Abstract] [Full Text] [Related]
17. The effects of the carbonic anhydrase inhibitor 6063 on electrolytes and acid-base balance in two normal subjects and two patients with respiratory acidosis. NADELL J. J Clin Invest; 1953 Jul 01; 32(7):622-9. PubMed ID: 13069607 [No Abstract] [Full Text] [Related]
18. Inhibition of cerebrospinal fluid formation by a carbonic anhydrase inhibitor, 2-acetylamino-1,3,4-thiadiazole-5-sulfonamide (diamox). TSCHIRGI RD, FROST RW, TAYLOR JL. Proc Soc Exp Biol Med; 1954 Nov 01; 87(2):373-6. PubMed ID: 13237248 [No Abstract] [Full Text] [Related]